Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies.
about
miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinomaProgression inference for somatic mutations in cancer.Gastric adenocarcinoma.AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells.Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma.Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
P2860
Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@en
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@nl
type
label
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@en
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@nl
prefLabel
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@en
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@nl
P2093
P2860
P356
P1433
P1476
Loss of ARID1A expression pred ...... meta-analysis from 14 studies.
@en
P2093
Huihua Xiong
Rongxian Zhao
Yingxing Wu
P2860
P2888
P356
10.1038/SREP28919
P407
P577
2016-06-29T00:00:00Z